Statistics for Pharmanutra S.p.A. (id:4951 PHN)

Valuation metrics

Market cap

539.90M

Enterprise value

548.09M

Trailing P/E (ttm)

32.96

Forward P/E

26.15

PEG ratio

26.15

Price/Sales (ttm)

5.02

Price/Book (mrq)

9.84

Enterprise Value/Revenue

5.09

Enterprise Value/EBITDA

20.44

Overview

Shares outstanding

9.61M

Float

4.27M

Shares short

% Held by insiders

0.65%

% Held by institutions

0.15%

Average volume (10 days)

8.45K

Average volume (90 days)

Price summary

52-Week low

44.85

52-Week high

63.50

52-Week change

7.59%

Beta

0.34

50-Day moving average

56.60

200-Day moving average

53.45

Dividends and splits

Forward annual dividend rate

3.40

Forward annual dividend yield

0.06

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

1.41

Payout ratio

0.50

Dividend date

Ex-dividend date

May 06th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

13.47%

Operating margin

31.14%

Operational effectiveness

Return on assets

14.04%

Return on equity

28.01%

Income statement

Revenue (ttm)

11.16

Revenue per share (ttm)

11.16

Quarterly revenue growth (yoy)

1.41

Gross profit (ttm)

33.60M

EBITDA

30.97M

Net income to common (ttm)

14.50M

Diluted EPS (ttm)

1.69

Quarterly earnings growth (yoy)

141.30%

Balance sheet

Total cash (mrq)

21.81M

Total cash per share (mrq)

2.27

Total debt (mrq)

27.05M

Total Debt/Equity (mrq)

49.36

Current ratio (mrq)

210.60%

Book value per share (mrq)

5.66

Cash flow

Cash flow statement

19.74M

Levered free cash flow (LFCF)

14.48M